These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1330379)

  • 1. Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test.
    Turner EI; Watson MJ; Perry LA; White MC
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):389-97. PubMed ID: 1330379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of late-onset adrenal 3 beta-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries.
    Morán C; Tena G; Herrera J; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(3):315-20. PubMed ID: 7803981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Lobo RA
    Fertil Steril; 1996 Sep; 66(3):354-61. PubMed ID: 8751729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome.
    Sahin Y; Keleştimur F
    Eur J Endocrinol; 1997 Dec; 137(6):670-4. PubMed ID: 9437235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset congenital adrenal hyperplasia in women with hirsutism.
    Arnaout MA
    Eur J Clin Invest; 1992 Oct; 22(10):651-8. PubMed ID: 1333959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
    Azziz R; Bradley EL; Potter HD; Boots LR
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C; Reyna R; Boots LS; Azziz R
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
    Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adrenal cortex and virilization.
    McKenna TJ; Cunningham SK; Loughlin T
    Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D; Leigh A; Wilson C; Donaldson A; Franks S
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
    Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome.
    Vrbíklová J; Hill M; Stárka L; Vondra K; Sulcová J; Snajderová M; Cibula D; Pobisová Z; Bendlová B
    Exp Clin Endocrinol Diabetes; 2000; 108(7):455-62. PubMed ID: 11083066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome.
    Keleştimur F; Sahin Y
    Fertil Steril; 1999 Jun; 71(6):1075-8. PubMed ID: 10360913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.